Alerts will be sent to your verified email
Verify EmailSHIVALIK
|
Shivalik Rasayan
|
Albert David
|
Jenburkt Pharma
|
|
|---|---|---|---|
|
|
|||
|
|
|||
|
Capacity Utilization - Dimethoate
|
95.0 % | n/a | n/a |
|
Realization/Tonne - Dimethoate
|
299080.92 Rs/MT | n/a | n/a |
|
Realization/Tonne - Sodium hydrosulfide
|
4487.46 Rs/MT | n/a | n/a |
|
|
|||
|
|
6.54 % | 9.66 % | 18.49 % |
|
5yr average Equity Multiplier
|
1.82 | 1.63 | 1.17 |
|
5yr Average Asset Turnover Ratio
|
0.44 | 0.6 | 0.88 |
|
5yr Avg Net Profit Margin
|
7.94 % | 9.43 % | 18.1 % |
|
Price to Book
|
0.67 | 1.01 | 2.35 |
|
P/E
|
33.09 | 0.0 | 13.36 |
|
|
100.7 Days | -17.6 Days | -32.02 Days |
|
Inventory Days
|
80.64 Days | 49.52 Days | 24.72 Days |
|
Days Receivable
|
107.04 Days | 31.64 Days | 48.38 Days |
|
Days Payable
|
166.18 Days | 120.61 Days | 82.6 Days |
|
5yr Average Interest Coverage Ratio
|
8.55 | 86.77 | 87.2 |
|
5yr Avg ROCE
|
8.54 % | 12.77 % | 24.44 % |
|
5yr Avg Operating Profit Margin
|
17.6 % | 8.33 % | 22.46 % |
|
5 yr average Debt to Equity
|
0.2 | 0.03 | 0.02 |
|
5yr CAGR Net Profit
|
-1.04 % | n/a | 14.21 % |
|
5yr Average Return on Assets
|
3.57 % | 5.9 % | 15.8 % |
|
|
|||
|
Promoter Holding
|
47.37 % | 62.24 % | 46.62 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-2.68 % | 0.2 % | -0.94 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Shivalik Rasayan
|
Albert David
|
Jenburkt Pharma
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Operating Profit Break-Up
|
Operating Profit Break-Up
|
-
|
-
|
|
Asset Break-Up
|
Asset Break-Up
|
-
|
-
|